<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04275674</url>
  </required_header>
  <id_info>
    <org_study_id>A-ER-105-481</org_study_id>
    <nct_id>NCT04275674</nct_id>
  </id_info>
  <brief_title>Inflammasome Activation and Cortisol Metabolism in Obese Women With Recurrent Miscarriage</brief_title>
  <official_title>Dr. Pao-Lin Kuo (Department of Obstetrics and Gynecology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cheng-Kung University Hospital</source>
  <brief_summary>
    <textblock>
      The prevalence of obesity among women of reproductive age is increasing. Obesity represents a
      chronic low-grade inflammatory state and NLRP3 inflammasome plays a pivotal role in
      obesity-induced inflammation. Obesity is associated with an increased risk of recurrent
      miscarriage (RM), but the underlying mechanisms are unclear. Abnormal inflammasome activation
      was also identified in the endometrium of women who experienced RM. Given inflammasome
      activation has emerged as common pathophysiology in obesity-related disorder and RM, the
      investigators wonder whether inflammasome activation occurs in the uterine macrophages of
      obese women, and result in early reproductive failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      pending
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validity of inflammatory markers</measure>
    <time_frame>1 Day</time_frame>
    <description>Use the levels of hsCRP and CA125 provides the information about inflammation.</description>
  </primary_outcome>
  <enrollment type="Anticipated">57</enrollment>
  <condition>Obesity</condition>
  <condition>Inflammation</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cases were referred for 200 women who have experienced at least two consecutive
        miscarriages are recruited from outpatient clinics of our hospital, including at least 50
        obese women
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All women have conceived naturally without the aid of assisted reproductive technologies

        Exclusion Criteria:

        N/A
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pao-Lin Kuo, MD</last_name>
    <phone>886-6-2353535</phone>
    <phone_ext>5262</phone_ext>
    <email>paolink@mail.ncku.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>PL Kuo, MD</last_name>
    <phone>886-6-2353535</phone>
    <phone_ext>5262</phone_ext>
    <email>paolink@mail.ncku.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Cheng-Kung University Hospital</name>
      <address>
        <city>Tainan</city>
        <zip>70428</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pao-Lin Kuo, MD</last_name>
      <phone>886-6-2353535</phone>
      <phone_ext>5262</phone_ext>
      <email>paolink@mail.ncku.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Pao-Lin Kuo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 28, 2019</study_first_submitted>
  <study_first_submitted_qc>February 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2020</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

